Adoptive T cell therapies, including chimeric antigen receptor (CAR) T cell therapy, which use genetically engineered killer immune T cells, are emerging forms of immunotherapy that redirect the immune system to target cancer.
May 19, 2020
0
80
Dendritic cells (DCs) are one of our bodies' first line of defense against invaders, and are stationed like sentinels at all outer and inner surfaces as well as in most of our organs. When they detect something foreign, they ...
May 18, 2020
0
73
A Ludwig Cancer Research study has discovered a novel means by which bacterial colonies in the small intestine support the generation of regulatory T cells—immune cells that suppress autoimmune reactions and inflammation. ...
Apr 16, 2020
0
419
Mount Sinai researchers have discovered a pathway that regulates special immune system cells in lung cancer tumors, suppressing them and allowing tumors to grow. The scientists also figured out how to interrupt this pathway ...
Mar 30, 2020
0
508
A team of researchers from Humboldt-Universität zu Berlin, Universitätsmedizin Berlin and the Foundation for Research and Technology-Hellas (IMBB-FORTH) has found evidence of previously unknown electrical properties in ...
Dying cells in the body can keep the immune system in check, thus preventing unwanted immune responses against the body's own tissues. Scientists from the German Cancer Research Center have now identified a receptor on murine ...
Jan 8, 2020
0
139
Autoimmune disorders such as rheumatoid arthritis, psoriasis, and Crohn's disease plague tens of millions of Americans and are the result of the body's immune system, whose role is to fight against disease-causing pathogens, ...
Dec 12, 2019
0
57
New research suggests that during decision-making, neurons in the brain are capable of much more complex processing than previously thought.
Nov 15, 2019
0
1503
Using a precursor to dendritic cells appears to be an efficient and effective way to stimulate the immune system to fight cancer tumors, according to a study in animal and cell models by researchers at the Duke Cancer Institute.
Nov 14, 2019
0
405
When immune cells detect harmful pathogens or cancer, they mobilise and coordinate a competent defence response. To do this effectively immune cells must communicate in a way that is tailored to the pathogenic insult. Consequently, ...
Sep 17, 2019
0
308
